[go: up one dir, main page]

ZA200704449B - Perorally administrable antimicrobial composition - Google Patents

Perorally administrable antimicrobial composition

Info

Publication number
ZA200704449B
ZA200704449B ZA200704449A ZA200704449A ZA200704449B ZA 200704449 B ZA200704449 B ZA 200704449B ZA 200704449 A ZA200704449 A ZA 200704449A ZA 200704449 A ZA200704449 A ZA 200704449A ZA 200704449 B ZA200704449 B ZA 200704449B
Authority
ZA
South Africa
Prior art keywords
antimicrobial composition
composition
lactulose
perorally administrable
antibiotic
Prior art date
Application number
ZA200704449A
Other languages
English (en)
Inventor
Chicherin Dmitry Sergeevich
Kiselev Nikolai Alexandrovich
Original Assignee
Kiselev Nikolai Alexandrovich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36000449&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200704449(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kiselev Nikolai Alexandrovich filed Critical Kiselev Nikolai Alexandrovich
Publication of ZA200704449B publication Critical patent/ZA200704449B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200704449A 2004-08-30 2007-05-30 Perorally administrable antimicrobial composition ZA200704449B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2004126203/15A RU2284832C2 (ru) 2004-08-30 2004-08-30 Антимикробная композиция для перорального введения

Publications (1)

Publication Number Publication Date
ZA200704449B true ZA200704449B (en) 2008-08-27

Family

ID=36000449

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200704449A ZA200704449B (en) 2004-08-30 2007-05-30 Perorally administrable antimicrobial composition

Country Status (21)

Country Link
US (1) US8231871B2 (xx)
EP (1) EP1790357B1 (xx)
JP (1) JP5062480B2 (xx)
CN (1) CN101031321B (xx)
AT (1) ATE410185T1 (xx)
AU (1) AU2005280704B2 (xx)
BR (1) BRPI0514708A (xx)
CA (1) CA2620919C (xx)
DE (1) DE602005010280D1 (xx)
DK (1) DK1790357T3 (xx)
EA (1) EA010199B1 (xx)
ES (1) ES2314708T3 (xx)
MX (1) MX2007002291A (xx)
NZ (1) NZ554212A (xx)
PL (1) PL1790357T3 (xx)
PT (1) PT1790357E (xx)
RU (1) RU2284832C2 (xx)
TR (1) TR200703565T1 (xx)
UA (1) UA85608C2 (xx)
WO (1) WO2006025767A2 (xx)
ZA (1) ZA200704449B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004261143B2 (en) 2003-07-25 2009-11-05 Allergan Pharmaceuticals International Limited A doxycycline metal complex in a solid dosage form
EP1855690B1 (en) * 2005-01-21 2016-06-01 Warner Chilcott Company, LLC A tetracycline metal complex in a solid dosage form
RU2325166C1 (ru) * 2006-11-21 2008-05-27 Александр Владимирович Диковский Фармацевтическая композиция антибиотиков и лактулозы для профилактики энтеральных дисбиозов в процессе антибиотикотерапии
RU2325187C1 (ru) * 2006-11-21 2008-05-27 Александр Владимирович Диковский Фармацевтическая композиция антибиотиков и пребиотиков (варианты) для профилактики и лечения дисбиозов в процессе антибактериальной терапии
HRP20151402T1 (hr) 2008-03-18 2016-04-08 Dikovskiy, Aleksander Vladimirovich Farmaceutski pripravak antibiotika i prebiotika za prevenciju i liječenje disbioze tijekom antibakterijske terapije
DK2266582T3 (en) * 2008-03-18 2015-07-27 Dikovskiy Aleksander Vladimirovich PHARMACEUTICAL COMPOSITION FOR PREVENTING DYSBIOSIS IN CONNECTION WITH ENTERAL ADMINISTRATION OF ANTIBIOTICS
RU2415684C2 (ru) * 2008-04-16 2011-04-10 Александр Владимирович Диковский Фармацевтическая композиция для лечения и/или профилактики дисбиозов кишечника в процессе проведения антибактериальной терапии у теплокровных животных: крупного рогатого скота, свиней, домашних животных, в частности собак, кошек, и сельскохозяйственных птиц и способ лечения и/или профилактики дисбиозов кишечника в процессе проведения антибактериальной терапии у теплокровных животных: крупного рогатого скота, свиней, домашних животных, в частности собак, кошек, и сельскохозяйственных птиц
CN105189750B (zh) 2013-05-07 2020-07-28 珀金埃尔默健康科学有限公司 使用粘土矿物和碱性溶液制备含核酸样品的方法
CN113476472A (zh) * 2021-07-22 2021-10-08 中国科学院烟台海岸带研究所 一种用于缓解肠道紊乱的益生元组合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582068A (en) * 1977-12-09 1980-12-31 Morinaga Milk Industry Co Ltd Powder composition comprising viable bifidobacteria cells containing powder and lactulose containing powder
IL75800A (en) * 1984-07-23 1988-11-30 Lilly Co Eli Pharmaceutical formulations comprising ceftazidime pentahydrate and amorphous lactose
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
JPH0614862B2 (ja) * 1987-05-22 1994-03-02 東京田辺製薬株式会社 ビフィドバクテリウム菌の増殖促進剤
JPS6483025A (en) * 1987-09-24 1989-03-28 Fujio Hayashi Blended preparation of drug-resistant live bacterium agent for controlling intestinal function and antibacterial agent
IE68841B1 (en) * 1988-03-18 1996-07-10 Duphar Int Res Method of preparing solid lactulose
FI87880C (fi) * 1990-06-27 1993-03-10 Valio Meijerien Foder som befraemjar tillvaexten och tarmfunktionen hos djur
JP3867171B2 (ja) * 1994-04-22 2007-01-10 アステラス製薬株式会社 結腸特異的薬物放出システム
ATE197900T1 (de) * 1996-08-15 2000-12-15 Losan Pharma Gmbh Gut schluckbare orale arzneiform
JPH10194975A (ja) * 1997-01-10 1998-07-28 Morinaga Milk Ind Co Ltd 肝疾患治療剤
IT1297538B1 (it) * 1997-08-01 1999-12-17 Francesco Vicidomini Enteroclisma di lattulosio/lattitolo con o senza aggiunta di neomicina per la cura della encefalopatia portosistemica acuta
FR2769839B1 (fr) * 1997-10-21 1999-12-17 Odette Mercedes Salsarulo Composition anhydre a base de lactulose
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
RU2131260C1 (ru) * 1998-10-14 1999-06-10 Плисов Николай Валерьевич Препарат для лечения желудочно-кишечных заболеваний
ATE248187T1 (de) * 1999-03-03 2003-09-15 Lilly Co Eli Echinocandin-kohlenhydrate-komplexe
EP1184038B1 (en) * 1999-06-09 2005-12-28 Mochida Pharmaceutical Co., Ltd. System for release in lower digestive tract

Also Published As

Publication number Publication date
BRPI0514708A (pt) 2008-06-24
WO2006025767A2 (fr) 2006-03-09
EP1790357B1 (en) 2008-10-08
JP5062480B2 (ja) 2012-10-31
TR200703565T1 (tr) 2007-08-21
EA200700357A1 (ru) 2008-06-30
CA2620919A1 (en) 2006-03-09
AU2005280704B2 (en) 2010-10-07
EP1790357A4 (en) 2007-11-07
CN101031321A (zh) 2007-09-05
RU2284832C2 (ru) 2006-10-10
ATE410185T1 (de) 2008-10-15
JP2008511622A (ja) 2008-04-17
ES2314708T3 (es) 2009-03-16
NZ554212A (en) 2009-08-28
DK1790357T3 (da) 2009-02-02
US8231871B2 (en) 2012-07-31
EA010199B1 (ru) 2008-06-30
PL1790357T3 (pl) 2009-03-31
US20070254023A1 (en) 2007-11-01
CN101031321B (zh) 2010-12-15
MX2007002291A (es) 2008-02-12
UA85608C2 (ru) 2009-02-10
PT1790357E (pt) 2008-12-31
WO2006025767A8 (en) 2007-04-05
DE602005010280D1 (de) 2008-11-20
EP1790357A2 (en) 2007-05-30
WO2006025767A3 (fr) 2006-08-17
RU2004126203A (ru) 2006-02-10
AU2005280704A1 (en) 2006-03-09
CA2620919C (en) 2014-10-14

Similar Documents

Publication Publication Date Title
ZA200704449B (en) Perorally administrable antimicrobial composition
BR0008059A (pt) Composições de valdecoxib
GR3020984T3 (en) Use of rifaximin and pharmaceutical compositions containing it in the treatment of gastric dyspepsia caused by helicobacter pylori.
WO2002101412A3 (en) Spray freeze-dried compositions
WO2005041934A3 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
HUP0302622A2 (hu) Ellenőrzött hatóanyag-leadású, biológiailag lebontható mikrorészecskék, amelyek csökkentett molekulatömegű, tisztított amilopektinalapú keményítőt tartalmaznak
MXPA04007427A (es) Formulaciones de azitromicina granuladas por via seca.
WO2003053399A3 (en) Methods for wet granulating azithromycin
CA2460865A1 (en) Quinoline derivatives as neuropeptide y antagonists
WO2008039406A3 (en) Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist
WO2006021160A8 (fr) Système de relargage de médicament auto-émulsifiant à base de butylbenzènephtaléine, méthode de préparation et applications d’un tel système
IL260229B2 (en) Suspension formulations of st-246 (tecovirimate monohydrate)
WO2007128495A3 (en) Solid pharmaceutical composition of gabapentin
BG103958A (en) Pharmaceutical compositions of thioxanide and nitazoxanide
WO2000054780A3 (en) Corticosteroid formulation
WO2007087344A3 (en) Anti-histamine compositions and use thereof
WO2003066022A3 (en) Stable pharmaceutical composition useful for treating gastrointestinal disorders
WO2002096354A3 (en) Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
US20180250227A1 (en) Nanosuspension formulation
WO2003039437A3 (de) Oral verabreichbare pharmazeutische zubereitung umfassend liposo mal verkapseltes taxol
WO2005065685A8 (en) Controlled release pharmaceutical composition comprising an acid-insoluble polymer and a bioadhesive polymer
Nord Effect of quinolones on the human intestinal microflora
WO2007119249A3 (en) Pharmaceutical compositions of cefixime
WO2008009589A3 (en) Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient
WO2004096181A3 (en) Solid dosage form comprising desmopressin